收藏切换
Integrating network pharmacology and in silico validation to decipher the therapeutic mechanism of Testudinis Carapax et Plastrum in Parkinson disease treatment
收藏切换
Xinyue ZHOU1, Ling XIAO2, Xiaopei LI1, 3, Weidong MAO4, Shan GUO5, *, Hankun HU1, *
World Clinical Drug | 2026, 47(8) : 841 - 852
Less
收藏切换
World Clinical Drug | 2026, 47(8): 841-852
• Article •
Integrating network pharmacology and in silico validation to decipher the therapeutic mechanism of Testudinis Carapax et Plastrum in Parkinson disease treatment
Full
Xinyue ZHOU1, Ling XIAO2, Xiaopei LI1, 3, Weidong MAO4, Shan GUO5, *, Hankun HU1, *
Affiliations
  • 1.Department of Pharmacy, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan 430071, Hubei Province, China
  • 2.Hubei Institute for Drug Control, NMPA Key Laboratory of Quality Control of Chinese Medicine Hubei, Engineering Research Center for Drug Quality Control, Wuhan 430075, Hubei Province, China
  • 3.Humanwell Healthcare(Group) Co., Ltd., Wuhan 430070, Hubei Province, China
  • 4.Department of Information Technology, Georgia Gwinnett College, Lawrenceville 30043, Georgia, USA
  • 5.Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Urological Diseases, Wuhan 430071, Hubei Province, China
Published: 2026-08-10 doi: 10.13683/j.wph.2026.08.003
Outline
收藏切换
Objective

To elucidate the potential mechanism of Testudinis Carapax et Plastrum(TCP) in treating Parkinson disease(PD) based on network pharmacology and computational validation.

Methods

Chemical components of TCP and their potential targets were retrieved from the BATMAN and HERB online TCM databases. PD-related targets were obtained from the GeneCards database. A protein-protein interaction(PPI) network was constructed using the STRING platform, and further topological analysis was performed with Cytoscape software(version 3.10.3). Tissue expression profiling of the targets was analyzed using the BioGPS database. Functional enrichment analysis of biological processes and signaling pathways was conducted via the DAVID database. Molecular docking and molecular dynamics simulations were employed to validate the interactions between components and targets.

Results

A total of 42 chemical components and 971 potential targets of TCP were identified. Intersection with 547 PD-related targets yielded 95 common targets. PPI topological analysis identified key targets, including insulin, tumor necrosis factor, interleukin-1β, peroxisome proliferator-activated receptor γ(PPARG), α-synuclein, and estrogen receptor 1(ESR1), which were significantly enriched in the nervous and immune systems. KEGG enrichment analysis indicated that TCP may regulate neurotransmitter transmission, immune-inflammatory responses, oxidative stress, and metabolic processes through pathways such as the phosphoinositide 3-kinase-Akt and cyclic adenosine monophosphate signaling pathways. Molecular docking and molecular dynamics simulations confirmed that the interactions between the ligands and receptors in the mestranol-ESR1, enoxolone-ESR1, and enoxolone-PPARG complexes were stable and strong.

Conclusion

TCP exerts anti-PD effects through a multi-component, multi-target, and multi-pathway synergistic mechanism. This study provides a theoretical basis for the clinical application of TCP in PD treatment.

Testudinis Carapax et Plastrum  /  Parkinson disease  /  network pharmacology  /  molecular docking  /  molecular dynamics simulation
周心悦, 肖凌, 李小培, 毛维东, 郭珊, 胡汉昆. 整合网络药理学与计算机模拟验证阐释龟甲治疗帕金森病的作用机制. 世界临床药物, 2026 , 47 (8) : 841 -852 . DOI: 10.13683/j.wph.2026.08.003
Xinyue ZHOU, Ling XIAO, Xiaopei LI, Weidong MAO, Shan GUO, Hankun HU. Integrating network pharmacology and in silico validation to decipher the therapeutic mechanism of Testudinis Carapax et Plastrum in Parkinson disease treatment[J]. World Clinical Drug, 2026 , 47 (8) : 841 -852 . DOI: 10.13683/j.wph.2026.08.003
Year 2026 volume 47 Issue 8
73
15
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.08.003
  • Receive Date:2026-02-02
  • Online Date:2026-11-05
  • Published:2026-08-10
Article Data
Affiliations
History
  • Received:2026-02-02
Funding
Affiliations
    1.Department of Pharmacy, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan 430071, Hubei Province, China
    2.Hubei Institute for Drug Control, NMPA Key Laboratory of Quality Control of Chinese Medicine Hubei, Engineering Research Center for Drug Quality Control, Wuhan 430075, Hubei Province, China
    3.Humanwell Healthcare(Group) Co., Ltd., Wuhan 430070, Hubei Province, China
    4.Department of Information Technology, Georgia Gwinnett College, Lawrenceville 30043, Georgia, USA
    5.Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Urological Diseases, Wuhan 430071, Hubei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.08.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT